GameSpot may receive revenue from affiliate and advertising partnerships for sharing this content and from purchases through links. A trio of Far Cry games, headlined by Far Cry 3, is getting a frame ...

The House-passed Republican reconciliation plan would cut nearly $300 billion from the Supplemental Nutrition Assistance Program (SNAP) through 2034, based on Congressional Budget Office (CBO) ...

As the 2025 calendar year rounds out, CNBC has ranked the top-25 college athletic programs by valuation. Texas has skyrocketed to the No. 1 spot, worth $1.48 billion. This number is 16% more than it ...

Local AI inference at 32B-parameter quality, no cloud API required: University of Waterloo researchers released PAW on July 2 ...

The Council for the Indian School Certificate Examinations (CISCE) has released the ISC Computer Science (Subject Code - 868) for the Year 2027 evaluation cycle. It is designed specifically to make ...

A trio of common amino acids may hold the key to unlocking far more powerful gene therapies. Researchers found that adding them to lipid nanoparticles can boost mRNA delivery up to 20-fold and push ...

AUSTIN (KXAN) — Data analyst Corey Yeung created the ATX Running Guide to help runners find community across Central Texas. What started as a personal project has become one of Austin’s most ...

Learning to program in C on an online platform can provide structured learning and a certification to show along with your resume. Learning C can still be useful in 2026, especially if you want to ...

Version 0.3.17 or latest supports qwen3-VL. Version 0.3.30 or latest supports qwen3.5. Version 0.3.35 or latest supports gemma4.

OSAKA, Japan & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Takeda (TSE:4502/NYSE:TAK) today presented additional results from two pivotal studies at SLEEP 2026, showing oveporexton (TAK-861), an oral orexin ...

Takeda ( TSE:4502/NYSE:TAK) today presented additional results from two pivotal studies at SLEEP 2026, showing oveporexton (TAK-861), an oral orexin receptor 2 (OX2R)-selective agonist, improved daily ...

- Secondary and Exploratory Endpoint Results from Phase 3 Studies Presented at SLEEP 2026 Underscore Improvements with Oveporexton Across a Broad Range of Daytime and Nighttime Symptoms - Takeda is on ...